Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations is a research paper published in Infectious Disease Clinics of North America (2020). On theSindex it has a DataRank of 0.722. It has been cited 122 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.722
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01 AI100560
BLRD VA
Grant: I01 BX001974
NIAID NIH HHS
Grant: R01 AI063517
NIAID NIH HHS
Grant: R01 AI072219
BLRD VA
Grant: I01 BX002872
National Institutes of Health
Grant: 5R01AI072219-12
Understanding B-Lactam Resistance in Acinetobacter baumannii
National Institutes of Health
Grant: 5I01BX002872-03
Targeting Burkholderial beta-lactamases: Structure, function, and regulation
National Institutes of Health
Grant: 5I01BX001974-11
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1
National Institutes of Health
Grant: 5R01AI063517-13
Challenges in beta-Lactamase Mediated Resistance
National Institutes of Health
Grant: 5R01AI100560-04
A Mechanism-Based Approach to Metallo-beta-Lactamase Inhibition
National Institutes of Health
U.S. Department of Veterans Affairs
FWCI
5.06
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals